US8425887B2ActiveUtilityA1
Amide dendrimer compositions
Est. expirySep 29, 2026(~0.2 yrs left)· nominal 20-yr term from priority
Inventors:Pradeep K. DhalDavid J. HarrisStephen Randall Holmes-FarleyChad C. HuvalVitaly NivorozhkinBruce Shutts
A61P 9/00A61P 43/00A61P 5/18A61P 3/12A61P 27/02A61P 3/14C08G 83/003C07C 235/08A61P 21/02C08G 69/40A61K 31/785A61K 8/72A61P 19/02C07C 237/10A61P 13/12C08L 101/00A61P 11/00
61
PatentIndex Score
0
Cited by
230
References
2
Claims
Abstract
Amide compounds, amide polymers, compositions including amide compounds and amide polymers may be used to bind target ions, such as phosphorous-containing compounds in the gastrointestinal tract of animals. In some cases, amide compounds and amide polymers may include a core derived from an amide polyol and an organic polyacid or ester.
Claims
exact text as granted — not AI-modifiedWhat is claimed is:
1. A pharmaceutical composition comprising:
a) at least one amide compound represented by the following Formula I:
wherein
R 3 is independently represented by the following Formula II:
wherein
p, q and r independently represent an integer from 0-2;
R 4 independently represents
wherein
m independently represents an integer from 1-20;
R 5 independently represents a hydrogen radical; a substituted or un-substituted alkyl radical; a substituted or un-substituted aryl radical; or R 5 and a neighboring R 5 together represent a link or links comprising a residue of a crosslinking agent, a substituted or un-substituted alicyclic radical, a substituted or un-substituted aromatic radical, or a substituted or un-substituted heterocyclic radical; or R 5 represents a link with another compound;
b) a crosslinking agent or residue thereof; and
c) a pharmaceutically acceptable excipient.
2. The pharmaceutical composition according to claim 1 , wherein the amide compound is represented by the following Formula IV:Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.